Furlanello F, Disertori M, Vergara G
G Ital Cardiol. 1980;10(10):1431-3.
The electrophysiological basis of the treatment of hyperkinetic "refractory" arrhythmias with rate - programmable pacemakers, stems from the pacing-inducted electrophysiological modifications with higher and time programmable threshold rates being obtainable to suppress the arrhythmias. Furthermore antiarrhythmic agents, that must be generally associated, are more safely employed. This is a new application in clinical arrhythmology of a particular type of permanent pacemaker whose classic indications are well known. The Authors report their experience relative to 16 selected patients affected by severe cardiopathies. Three types of pacemakers were employed: Omnis Stanicor Cordis; Microlith C.P.I.; and Byrel A-V Sequential, Medtronic. The results, in term of the suppression of the arrhythmias, were encouraging. The most striking problem is to match the "rate threshold" for the suppression of the arrhythmia with the patient's hemodynamic tolerance: not infrequently in fact the programmed rates are poorly tolerated by the patient either because of heart failure or due to coronary insufficiency. These patients need frequent adjustment of the stimulation rate. The availability of rate programmable pacemakers with steps of one beat per minute, of A-V sequential stimulation and, when feasible of atrial stimulation, undoubtedly plays an important role in clinical arrhythmology.
用频率可编程起搏器治疗运动亢进性“难治性”心律失常的电生理基础,源于起搏诱导的电生理改变,通过设置更高且可随时间编程的阈值频率来抑制心律失常。此外,通常必须联合使用的抗心律失常药物也能更安全地应用。这是一种特殊类型的永久性起搏器在临床心律失常学中的新应用,其经典适应证广为人知。作者报告了他们对16例患有严重心脏病的选定患者的经验。使用了三种类型的起搏器:全功能斯坦尼康心脏起搏器;CPI微晶起搏器;以及美敦力公司的百瑞房室顺序起搏器。就心律失常的抑制而言,结果令人鼓舞。最突出的问题是使抑制心律失常的“频率阈值”与患者的血流动力学耐受性相匹配:事实上,由于心力衰竭或冠状动脉供血不足,患者往往对程控频率耐受性差。这些患者需要频繁调整刺激频率。每分钟步长为1次心跳的频率可编程起搏器、房室顺序刺激以及在可行时进行心房刺激,无疑在临床心律失常学中发挥着重要作用。